Biotechnology
The Biotechnology industry has a total of 630 stocks, with a combined market cap of $850.39 billion and total revenue of $100.99 billion.
Market Cap
850.39B
Revenue
100.99B
Profits
-38.28B
PE Ratio
n/a
Profit Margin
-37.90%
Dividend Yield
0.05%
629 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 96.31B | -2.60% | 3,995,539 | 11.42B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 58.04B | 0.84% | 811,285 | 14.21B |
| 3 | ALNY | Alnylam Pharmaceuticals, Inc. | 57.03B | 1.63% | 1,152,674 | 2.46B |
| 4 | ARGX | argenx SE | 40.99B | -0.12% | 333,554 | 3.12B |
| 5 | ONC | BeOne Medicines Ltd. | 32.82B | -0.08% | 406,110 | 4.56B |
| 6 | BNTX | BioNTech SE | 26.77B | 0.04% | 891,499 | 3.38B |
| 7 | RPRX | Royalty Pharma plc | 21.58B | -0.30% | 4,325,974 | 2.31B |
| 8 | SMMT | Summit Therapeutics Inc. | 20.85B | -1.58% | 1,718,588 | - |
| 9 | INSM | Insmed Incorporated | 20.76B | -1.76% | 3,335,166 | 398.11M |
| 10 | INCY | Incyte Corporation | 15.27B | 0.71% | 1,376,547 | 4.58B |
| 11 | GMAB | Genmab A/S | 13.87B | 5.49% | 3,055,929 | 3.23B |
| 12 | ASND | Ascendis Pharma A/S | 11.53B | 4.24% | 978,026 | 576.33M |
| 13 | BMRN | BioMarin Pharmaceutical Inc. | 11.42B | -1.99% | 2,104,340 | 3.06B |
| 14 | MRNA | Moderna, Inc. | 10.35B | -0.37% | 7,832,109 | 3.08B |
| 15 | EXEL | Exelixis, Inc. | 10.07B | -0.85% | 2,654,895 | 2.23B |
| 16 | VRNA | Verona Pharma plc | 9.08B | 0.01% | 1,860,830 | 221.67M |
| 17 | BBIO | BridgeBio Pharma, Inc. | 8.78B | 2.54% | 2,662,231 | 235.81M |
| 18 | CAI | Caris Life Sciences, Inc. | 7.95B | -1.24% | 520,264 | 452.50M |
| 19 | ROIV | Roivant Sciences Ltd. | 7.88B | -0.86% | 4,643,165 | 29.05M |
| 20 | TECH | Bio-Techne Corporation | 7.86B | 0.56% | 3,135,251 | 1.22B |
| 21 | MDGL | Madrigal Pharmaceuticals, Inc. | 7.63B | 1.24% | 381,466 | 515.55M |
| 22 | CORT | Corcept Therapeutics Incorporated | 7.53B | 1.36% | 712,355 | 716.08M |
| 23 | HALO | Halozyme Therapeutics, Inc. | 7.26B | -0.35% | 2,142,882 | 1.18B |
| 24 | LEGN | Legend Biotech Corporation | 6.90B | -0.61% | 884,864 | 728.30M |
| 25 | JAZZ | Jazz Pharmaceuticals plc | 6.80B | 5.81% | 1,601,206 | 4.09B |
| 26 | IONS | Ionis Pharmaceuticals, Inc. | 6.54B | 0.89% | 2,741,662 | 944.05M |
| 27 | RVMD | Revolution Medicines, Inc. | 6.53B | -4.69% | 3,793,905 | - |
| 28 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.14B | 2.74% | 557,370 | 156.29M |
| 29 | RNA | Avidity Biosciences, Inc. | 5.73B | -1.53% | 4,312,537 | 10.73M |
| 30 | ABVX | ABIVAX Société Anonyme | 5.32B | 1.35% | 1,145,384 | 11.44M |
| 31 | AXSM | Axsome Therapeutics, Inc. | 5.21B | 1.03% | 411,735 | 495.03M |
| 32 | NUVL | Nuvalent, Inc. | 5.18B | -6.56% | 686,409 | - |
| 33 | CRSP | CRISPR Therapeutics AG | 5.09B | -0.67% | 1,906,880 | 38.05M |
| 34 | MRUS | Merus N.V. | 4.79B | -3.28% | 560,860 | 56.23M |
| 35 | CYTK | Cytokinetics, Incorporated | 4.21B | 0.31% | 1,050,432 | 85.74M |
| 36 | SLNO | Soleno Therapeutics, Inc. | 4.16B | -3.06% | 1,780,032 | 32.66M |
| 37 | ACAD | ACADIA Pharmaceuticals Inc. | 4.08B | 2.52% | 2,149,580 | 1.02B |
| 38 | TGTX | TG Therapeutics, Inc. | 4.07B | 0.69% | 2,482,613 | 454.07M |
| 39 | AKRO | Akero Therapeutics, Inc. | 4.02B | -4.43% | 1,718,822 | - |
| 40 | TLX | Telix Pharmaceuticals Limited | 4.00B | -1.59% | 31,498 | 484.69M |
| 41 | ADMA | ADMA Biologics, Inc. | 4.00B | -9.65% | 11,887,396 | 474.17M |
| 42 | VKTX | Viking Therapeutics, Inc. | 4.00B | 11.54% | 8,544,877 | - |
| 43 | PTCT | PTC Therapeutics, Inc. | 3.99B | -1.95% | 870,024 | 1.76B |
| 44 | AAPG | Ascentage Pharma Group International | 3.97B | 0.30% | 3,054 | 134.35M |
| 45 | KRYS | Krystal Biotech, Inc. | 3.94B | 0.07% | 322,732 | 359.21M |
| 46 | ACLX | Arcellx, Inc. | 3.92B | 0.68% | 699,258 | 56.98M |
| 47 | PCVX | Vaxcyte, Inc. | 3.90B | -9.06% | 2,627,865 | - |
| 48 | ZLAB | Zai Lab Limited | 3.77B | -11.98% | 1,673,189 | 427.80M |
| 49 | MLTX | MoonLake Immunotherapeutics | 3.30B | -1.65% | 303,015 | - |
| 50 | MTSR | Metsera, Inc. | 3.25B | -7.60% | 1,922,167 | - |
| 51 | PTGX | Protagonist Therapeutics, Inc. | 3.17B | -5.40% | 901,652 | 209.18M |
| 52 | APLS | Apellis Pharmaceuticals, Inc. | 3.07B | 2.53% | 2,599,686 | 754.65M |
| 53 | SRRK | Scholar Rock Holding Corporation | 3.02B | -9.30% | 3,460,204 | - |
| 54 | MIRM | Mirum Pharmaceuticals, Inc. | 3.01B | 12.04% | 2,046,679 | 429.16M |
| 55 | KYMR | Kymera Therapeutics, Inc. | 2.87B | -1.21% | 538,645 | 58.89M |
| 56 | IMVT | Immunovant, Inc. | 2.69B | -1.44% | 688,904 | - |
| 57 | RARE | Ultragenyx Pharmaceutical Inc. | 2.68B | -0.78% | 1,880,426 | 610.16M |
| 58 | CRNX | Crinetics Pharmaceuticals, Inc. | 2.61B | -2.28% | 1,067,661 | 760.00K |
| 59 | XENE | Xenon Pharmaceuticals Inc. | 2.58B | -1.87% | 602,944 | 7.50M |
| 60 | NAMS | NewAmsterdam Pharma Company N.V. | 2.58B | -2.79% | 700,090 | 64.01M |
| 61 | CPRX | Catalyst Pharmaceuticals, Inc. | 2.40B | -9.89% | 3,920,994 | 558.50M |
| 62 | RXRX | Recursion Pharmaceuticals, Inc. | 2.35B | -1.28% | 14,341,865 | 64.60M |
| 63 | CNTA | Centessa Pharmaceuticals plc | 2.30B | 0.12% | 726,168 | 15.00M |
| 64 | BLTE | Belite Bio, Inc | 2.28B | 3.09% | 141,297 | - |
| 65 | ARWR | Arrowhead Pharmaceuticals, Inc. | 2.22B | -1.53% | 1,638,236 | 572.98M |
| 66 | GLPG | Galapagos NV | 2.16B | 0.24% | 189,415 | 323.67M |
| 67 | AGIO | Agios Pharmaceuticals, Inc. | 2.15B | -1.75% | 529,072 | 40.88M |
| 68 | OCUL | Ocular Therapeutix, Inc. | 2.14B | -1.60% | 2,407,156 | 56.66M |
| 69 | IBRX | ImmunityBio, Inc. | 2.12B | 1.05% | 7,918,140 | 56.60M |
| 70 | APGE | Apogee Therapeutics, Inc. | 2.10B | -0.88% | 481,017 | - |
| 71 | FOLD | Amicus Therapeutics, Inc. | 2.09B | -2.02% | 4,078,586 | 571.16M |
| 72 | DNLI | Denali Therapeutics Inc. | 2.07B | -0.84% | 2,079,926 | - |
| 73 | TARS | Tarsus Pharmaceuticals, Inc. | 2.02B | 15.15% | 1,559,901 | 295.52M |
| 74 | IRON | Disc Medicine, Inc. | 1.98B | -3.27% | 346,532 | - |
| 75 | HRMY | Harmony Biosciences Holdings, Inc. | 1.97B | -1.38% | 400,855 | 772.53M |
| 76 | IDYA | IDEAYA Biosciences, Inc. | 1.96B | -5.16% | 673,041 | 7.00M |
| 77 | MESO | Mesoblast Limited | 1.96B | -2.36% | 177,424 | 5.67M |
| 78 | ADPT | Adaptive Biotechnologies Corporation | 1.91B | 7.27% | 5,150,708 | 205.22M |
| 79 | CGON | CG Oncology, Inc. | 1.86B | -3.72% | 633,682 | 662.00K |
| 80 | VCEL | Vericel Corporation | 1.82B | -0.39% | 556,165 | 249.12M |
| 81 | CELC | Celcuity Inc. | 1.80B | 0.11% | 649,219 | - |
| 82 | SRPT | Sarepta Therapeutics, Inc. | 1.75B | 10.46% | 16,576,781 | 2.48B |
| 83 | BEAM | Beam Therapeutics Inc. | 1.74B | -2.40% | 1,798,805 | 60.27M |
| 84 | SPRY | ARS Pharmaceuticals, Inc. | 1.73B | -1.84% | 741,271 | 97.12M |
| 85 | ARQT | Arcutis Biotherapeutics, Inc. | 1.69B | -8.07% | 4,359,634 | 263.47M |
| 86 | LQDA | Liquidia Corporation | 1.64B | -5.42% | 1,875,335 | 14.14M |
| 87 | IMCR | Immunocore Holdings plc | 1.60B | -0.53% | 593,077 | 356.15M |
| 88 | DYN | Dyne Therapeutics, Inc. | 1.59B | -3.45% | 3,613,407 | - |
| 89 | BHVN | Biohaven Ltd. | 1.56B | 1.13% | 1,218,084 | - |
| 90 | COGT | Cogent Biosciences, Inc. | 1.52B | -1.00% | 1,729,346 | - |
| 91 | TVTX | Travere Therapeutics, Inc. | 1.51B | -1.91% | 3,757,435 | 333.87M |
| 92 | AUPH | Aurinia Pharmaceuticals Inc. | 1.50B | -1.55% | 3,327,417 | 260.11M |
| 93 | PHVS | Pharvaris N.V. | 1.47B | -4.29% | 89,273 | - |
| 94 | NVAX | Novavax, Inc. | 1.43B | 15.83% | 17,691,911 | 1.08B |
| 95 | CLDX | Celldex Therapeutics, Inc. | 1.41B | -1.07% | 841,052 | 5.79M |
| 96 | CDTX | Cidara Therapeutics, Inc. | 1.37B | -0.42% | 325,773 | 302.00K |
| 97 | EWTX | Edgewise Therapeutics, Inc. | 1.36B | -4.18% | 796,141 | - |
| 98 | VRDN | Viridian Therapeutics, Inc. | 1.35B | -3.90% | 818,940 | 305.00K |
| 99 | JANX | Janux Therapeutics, Inc. | 1.34B | -6.62% | 1,218,866 | 439.00K |
| 100 | ETNB | 89bio, Inc. | 1.32B | -4.85% | 1,777,875 | - |
| 101 | WVE | Wave Life Sciences Ltd. | 1.29B | -4.91% | 1,195,078 | 93.95M |
| 102 | ABCL | AbCellera Biologics Inc. | 1.27B | 2.91% | 8,570,893 | 23.11M |
| 103 | VERA | Vera Therapeutics, Inc. | 1.26B | 2.44% | 1,511,737 | - |
| 104 | ARDX | Ardelyx, Inc. | 1.24B | -1.15% | 4,277,075 | 386.15M |
| 105 | CVAC | CureVac N.V. | 1.23B | 0.18% | 479,950 | 566.04M |
| 106 | NTLA | Intellia Therapeutics, Inc. | 1.19B | 0.79% | 5,831,209 | 52.86M |
| 107 | INVA | Innoviva, Inc. | 1.16B | 1.12% | 1,545,383 | 370.23M |
| 108 | SNDX | Syndax Pharmaceuticals, Inc. | 1.10B | -1.32% | 2,141,291 | 77.93M |
| 109 | ELVN | Enliven Therapeutics, Inc. | 1.06B | -4.72% | 345,707 | - |
| 110 | XERS | Xeris Biopharma Holdings, Inc. | 1.06B | 20.22% | 10,175,486 | 246.03M |
| 111 | MNKD | MannKind Corporation | 1.05B | -1.01% | 4,581,442 | 301.74M |
| 112 | MDXG | MiMedx Group, Inc. | 1.05B | -1.80% | 651,501 | 363.77M |
| 113 | PRAX | Praxis Precision Medicines, Inc. | 994.83M | -2.74% | 241,648 | 7.77M |
| 114 | RCUS | Arcus Biosciences, Inc. | 987.68M | -2.21% | 1,478,472 | 262.00M |
| 115 | OCS | Oculis Holding AG | 982.15M | -1.04% | 5,007 | 847.33K |
| 116 | AVXL | Anavex Life Sciences Corp. | 957.95M | 2.23% | 924,593 | - |
| 117 | GPCR | Structure Therapeutics Inc. | 932.58M | -0.67% | 2,693,315 | - |
| 118 | SYRE | Spyre Therapeutics, Inc. | 920.51M | -4.51% | 417,785 | - |
| 119 | LENZ | LENZ Therapeutics, Inc. | 916.13M | 6.46% | 467,584 | 5.00M |
| 120 | QURE | uniQure N.V. | 915.97M | -0.30% | 629,106 | 14.34M |
| 121 | ZYME | Zymeworks Inc. | 910.11M | -2.01% | 394,059 | 122.87M |
| 122 | IOVA | Iovance Biotherapeutics, Inc. | 881.59M | 2.33% | 28,357,052 | 241.53M |
| 123 | ATAI | Atai Life Sciences N.V. | 880.40M | -0.95% | 4,373,563 | 1.86M |
| 124 | TRVI | Trevi Therapeutics, Inc. | 869.76M | 0.41% | 1,124,881 | - |
| 125 | IMNM | Immunome, Inc. | 859.13M | -5.64% | 1,109,311 | 12.59M |
| 126 | URGN | UroGen Pharma Ltd. | 858.88M | -7.10% | 1,825,999 | 94.24M |
| 127 | UPB | Upstream Bio, Inc. | 853.93M | -5.26% | 371,732 | 2.72M |
| 128 | MLYS | Mineralys Therapeutics, Inc. | 838.81M | -4.38% | 564,072 | - |
| 129 | PHAR | Pharming Group N.V. | 838.31M | -0.98% | 8,172 | 339.84M |
| 130 | GERN | Geron Corporation | 829.42M | -6.47% | 14,193,778 | 164.45M |
| 131 | ORIC | ORIC Pharmaceuticals, Inc. | 820.71M | -2.53% | 495,969 | - |
| 132 | CRMD | CorMedix Inc. | 804.58M | -9.54% | 14,037,645 | 121.48M |
| 133 | NUVB | Nuvation Bio Inc. | 796.22M | -0.43% | 4,844,229 | 14.36M |
| 134 | DNA | Ginkgo Bioworks Holdings, Inc. | 787.84M | -3.58% | 1,512,163 | 230.82M |
| 135 | NRIX | Nurix Therapeutics, Inc. | 769.85M | -3.73% | 450,626 | 88.38M |
| 136 | IMTX | Immatics N.V. | 768.20M | -0.32% | 328,720 | 155.80M |
| 137 | NAGE | Niagen Bioscience, Inc. | 768.03M | 2.23% | 3,099,198 | 116.30M |
| 138 | SION | Sionna Therapeutics, Inc. | 761.91M | 1.77% | 121,479 | - |
| 139 | MNMD | Mind Medicine (MindMed) Inc. | 760.12M | 1.01% | 966,475 | - |
| 140 | PROK | ProKidney Corp. | 750.78M | -10.94% | 2,766,748 | 306.00K |
| 141 | GHRS | GH Research PLC | 750.54M | -0.41% | 696,720 | - |
| 142 | TNGX | Tango Therapeutics, Inc. | 735.43M | 1.69% | 2,514,737 | 24.30M |
| 143 | STOK | Stoke Therapeutics, Inc. | 723.41M | 0.61% | 418,319 | 190.91M |
| 144 | VALN | Valneva SE | 709.29M | 0.73% | 100,031 | 201.10M |
| 145 | AMLX | Amylyx Pharmaceuticals, Inc. | 698.87M | -4.27% | 1,082,556 | -249.00K |
| 146 | EYPT | EyePoint Pharmaceuticals, Inc. | 692.93M | -4.82% | 785,022 | 51.90M |
| 147 | AVBP | ArriVent BioPharma, Inc. | 677.15M | -2.83% | 152,957 | - |
| 148 | SANA | Sana Biotechnology, Inc. | 669.90M | -30.12% | 31,410,182 | - |
| 149 | ZVRA | Zevra Therapeutics, Inc. | 663.26M | 5.66% | 1,456,831 | 40.59M |
| 150 | FTRE | Fortrea Holdings Inc. | 657.39M | 10.03% | 2,054,519 | 2.73B |
| 151 | PHAT | Phathom Pharmaceuticals, Inc. | 654.69M | 8.29% | 2,195,017 | 114.04M |
| 152 | GYRE | Gyre Therapeutics, Inc. | 652.73M | 2.56% | 103,735 | 100.64M |
| 153 | ABUS | Arbutus Biopharma Corporation | 651.78M | -2.02% | 590,215 | 15.42M |
| 154 | KALV | KalVista Pharmaceuticals, Inc. | 629.99M | -0.86% | 644,476 | - |
| 155 | AUTL | Autolus Therapeutics plc | 625.43M | 1.73% | 1,187,911 | 9.01M |
| 156 | PRME | Prime Medicine, Inc. | 622.01M | -9.58% | 6,621,088 | 4.96M |
| 157 | ZBIO | Zenas BioPharma, Inc. | 619.15M | -5.73% | 175,030 | 15.00M |
| 158 | DAWN | Day One Biopharmaceuticals, Inc. | 617.66M | 3.97% | 2,306,985 | 187.64M |
| 159 | DNTH | Dianthus Therapeutics, Inc. | 615.86M | -6.08% | 246,160 | 4.85M |
| 160 | MGTX | MeiraGTx Holdings plc | 612.38M | -3.77% | 230,444 | 34.51M |
| 161 | TSHA | Taysha Gene Therapies, Inc. | 603.20M | 0.72% | 1,641,376 | 7.22M |
| 162 | VIR | Vir Biotechnology, Inc. | 601.34M | -14.37% | 2,332,640 | 19.00M |
| 163 | RLAY | Relay Therapeutics, Inc. | 598.34M | -1.13% | 1,599,195 | 8.36M |
| 164 | MAZE | Maze Therapeutics, Inc. | 583.38M | -6.53% | 156,249 | 167.50M |
| 165 | TYRA | Tyra Biosciences, Inc. | 572.73M | -2.36% | 120,595 | - |
| 166 | ANAB | AnaptysBio, Inc. | 570.30M | -9.63% | 529,159 | 123.16M |
| 167 | RAPP | Rapport Therapeutics, Inc. | 562.43M | 5.48% | 334,278 | - |
| 168 | TBPH | Theravance Biopharma, Inc. | 560.51M | 0.27% | 199,284 | 65.27M |
| 169 | BCAX | Bicara Therapeutics Inc. | 556.27M | -2.30% | 238,399 | - |
| 170 | PGEN | Precigen, Inc. | 554.94M | 2.73% | 2,413,189 | 4.20M |
| 171 | SVRA | Savara Inc. | 554.11M | -4.01% | 485,970 | - |
| 172 | TRML | Tourmaline Bio, Inc. | 547.94M | -2.78% | 150,831 | - |
| 173 | RIGL | Rigel Pharmaceuticals, Inc. | 546.01M | 2.11% | 818,941 | 267.92M |
| 174 | KROS | Keros Therapeutics, Inc. | 542.62M | -7.29% | 708,314 | 232.84M |
| 175 | ATNF | 180 Life Sciences Corp. | 528.33M | -4.19% | 1,363,803 | - |
| 176 | XNCR | Xencor, Inc. | 522.08M | -2.27% | 1,106,975 | 146.93M |
| 177 | SEPN | Septerna, Inc. | 521.33M | -0.43% | 104,245 | 977.00K |
| 178 | BCYC | Bicycle Therapeutics plc | 516.63M | -1.32% | 133,831 | 25.72M |
| 179 | KURA | Kura Oncology, Inc. | 515.99M | -1.16% | 990,132 | 83.28M |
| 180 | MRVI | Maravai LifeSciences Holdings, Inc. | 515.69M | -0.49% | 3,268,014 | 241.86M |
| 181 | ORKA | Oruka Therapeutics, Inc. | 511.81M | -3.52% | 113,232 | - |
| 182 | TERN | Terns Pharmaceuticals, Inc. | 493.56M | -0.53% | 1,180,476 | - |
| 183 | RZLT | Rezolute, Inc. | 484.57M | -2.11% | 410,290 | - |
| 184 | SLDB | Solid Biosciences Inc. | 479.82M | -4.92% | 1,223,598 | - |
| 185 | OPT | Opthea Limited | 466.57M | - | - | 208.86K |
| 186 | ATYR | aTyr Pharma, Inc. | 466.38M | -1.87% | 4,011,163 | 235.00K |
| 187 | IVA | Inventiva S.A. | 464.33M | 4.00% | 17,620 | 14.59M |
| 188 | ARVN | Arvinas, Inc. | 458.13M | -2.95% | 3,268,830 | 372.80M |
| 189 | ITOS | iTeos Therapeutics, Inc. | 447.80M | 0.20% | 1,192,280 | 35.00M |
| 190 | ALMS | Alumis Inc. | 446.81M | -0.92% | 740,087 | 17.39M |
| 191 | PRTC | PureTech Health plc | 431.84M | 0.05% | 3,237 | 4.83M |
| 192 | KOD | Kodiak Sciences Inc. | 431.57M | -0.12% | 382,380 | - |
| 193 | PVLA | Palvella Therapeutics, Inc. | 428.96M | -0.69% | 66,848 | - |
| 194 | REPL | Replimune Group, Inc. | 426.38M | -0.36% | 5,852,698 | - |
| 195 | ABSI | Absci Corporation | 421.15M | 0.34% | 3,900,080 | 4.82M |
| 196 | PRTA | Prothena Corporation plc | 415.57M | -2.53% | 909,726 | 10.34M |
| 197 | CGEM | Cullinan Therapeutics, Inc. | 414.87M | -10.79% | 486,546 | - |
| 198 | ERAS | Erasca, Inc. | 413.60M | 2.10% | 549,338 | - |
| 199 | TNXP | Tonix Pharmaceuticals Holding Corp. | 410.32M | 2.85% | 865,065 | 10.04M |
| 200 | TECX | Tectonic Therapeutic, Inc. | 409.30M | -5.35% | 153,101 | - |
| 201 | LXRX | Lexicon Pharmaceuticals, Inc. | 406.76M | -2.61% | 3,480,954 | 58.43M |
| 202 | AURA | Aura Biosciences, Inc. | 406.13M | -4.24% | 125,389 | - |
| 203 | RGNX | REGENXBIO Inc. | 398.07M | -4.01% | 1,108,600 | 155.78M |
| 204 | GOSS | Gossamer Bio, Inc. | 395.64M | -12.12% | 3,782,644 | 40.24M |
| 205 | YMAB | Y-mAbs Therapeutics, Inc. | 387.14M | - | 1,240,772 | 88.66M |
| 206 | CMPX | Compass Therapeutics, Inc. | 384.43M | -4.47% | 375,025 | 850.00K |
| 207 | HUMA | Humacyte, Inc. | 383.14M | 11.76% | 4,617,972 | 517.00K |
| 208 | ATXS | Astria Therapeutics, Inc. | 376.42M | -4.44% | 216,078 | - |
| 209 | NKTR | Nektar Therapeutics | 376.30M | -3.12% | 345,121 | 87.25M |
| 210 | MBX | MBX Biosciences, Inc. | 372.01M | -4.63% | 327,239 | - |
| 211 | CAPR | Capricor Therapeutics, Inc. | 368.86M | 4.26% | 970,361 | 17.36M |
| 212 | FULC | Fulcrum Therapeutics, Inc. | 368.36M | -1.73% | 325,082 | 80.00M |
| 213 | NBTX | Nanobiotix S.A. | 336.08M | 4.20% | 6,656 | -7.44M |
| 214 | RCKT | Rocket Pharmaceuticals, Inc. | 332.91M | 2.32% | 2,230,214 | - |
| 215 | CTMX | CytomX Therapeutics, Inc. | 330.84M | -3.23% | 2,734,115 | 141.10M |
| 216 | ARCT | Arcturus Therapeutics Holdings Inc. | 324.90M | -1.88% | 265,249 | 143.68M |
| 217 | OLMA | Olema Pharmaceuticals, Inc. | 322.95M | -5.22% | 388,047 | - |
| 218 | ABEO | Abeona Therapeutics Inc. | 320.75M | -1.88% | 442,869 | - |
| 219 | CRVS | Corvus Pharmaceuticals, Inc. | 318.48M | -0.96% | 560,449 | - |
| 220 | XOMA | XOMA Royalty Corporation | 314.13M | -0.64% | 18,601 | 42.91M |
| 221 | LRMR | Larimar Therapeutics, Inc. | 313.26M | -2.92% | 1,056,079 | - |
| 222 | CADL | Candel Therapeutics, Inc. | 311.41M | -2.01% | 534,655 | - |
| 223 | ALDX | Aldeyra Therapeutics, Inc. | 309.66M | -0.96% | 606,510 | - |
| 224 | VSTM | Verastem, Inc. | 308.81M | -1.75% | 2,447,610 | 2.14M |
| 225 | BNTC | Benitec Biopharma Inc. | 308.44M | -0.43% | 50,350 | - |
| 226 | NGNE | Neurogene Inc. | 306.06M | 0.40% | 79,297 | 925.00K |
| 227 | INBX | Inhibrx Biosciences, Inc. | 302.69M | -0.33% | 68,478 | 200.00K |
| 228 | ADCT | ADC Therapeutics SA | 296.23M | - | 420,553 | 75.82M |
| 229 | AVIR | Atea Pharmaceuticals, Inc. | 296.10M | -0.86% | 306,049 | - |
| 230 | OCGN | Ocugen, Inc. | 292.30M | 4.35% | 2,500,755 | 4.75M |
| 231 | SGMT | Sagimet Biosciences Inc. | 291.37M | -1.31% | 417,650 | - |
| 232 | IMAB | I-Mab | 286.63M | -6.15% | 3,869,314 | 569.46K |
| 233 | ALT | Altimmune, Inc. | 285.50M | -2.22% | 2,430,024 | 20.00K |
| 234 | HRTX | Heron Therapeutics, Inc. | 280.72M | 1.66% | 1,144,230 | 148.52M |
| 235 | FHTX | Foghorn Therapeutics Inc. | 277.59M | 1.63% | 117,630 | 24.17M |
| 236 | DRTS | Alpha Tau Medical Ltd. | 276.97M | 4.64% | 167,366 | - |
| 237 | DBVT | DBV Technologies S.A. | 274.55M | -0.99% | 22,248 | 3.80M |
| 238 | RNAC | Cartesian Therapeutics, Inc. | 273.56M | -6.56% | 48,094 | 1.03M |
| 239 | FDMT | 4D Molecular Therapeutics, Inc. | 267.76M | 0.87% | 642,706 | 23.00K |
| 240 | IMMP | Immutep Limited | 267.13M | 3.43% | 161,378 | 3.02M |
| 241 | NMRA | Neumora Therapeutics, Inc. | 266.88M | 3.77% | 1,282,796 | - |
| 242 | SCPH | scPharmaceuticals Inc. | 264.49M | -4.75% | 338,250 | 49.97M |
| 243 | VOR | Vor Biopharma Inc. | 262.14M | -0.96% | 1,773,403 | - |
| 244 | GLUE | Monte Rosa Therapeutics, Inc. | 260.19M | -2.87% | 426,866 | 177.99M |
| 245 | ANNX | Annexon, Inc. | 260.02M | 0.85% | 884,051 | - |
| 246 | AARD | Aardvark Therapeutics, Inc. | 259.70M | -4.77% | 36,018 | - |
| 247 | SLN | Silence Therapeutics plc | 254.10M | 1.13% | 122,610 | 27.17M |
| 248 | OMER | Omeros Corporation | 253.74M | -2.20% | 498,898 | - |
| 249 | MREO | Mereo BioPharma Group plc | 251.22M | -0.63% | 1,339,441 | 1.00M |
| 250 | DMAC | DiaMedica Therapeutics Inc. | 249.14M | 2.12% | 565,420 | - |
| 251 | VNDA | Vanda Pharmaceuticals Inc. | 248.17M | -0.47% | 310,692 | 203.47M |
| 252 | MNPR | Monopar Therapeutics Inc. | 245.22M | -1.35% | 16,463 | - |
| 253 | GALT | Galectin Therapeutics Inc. | 243.04M | 1.86% | 164,333 | - |
| 254 | LXEO | Lexeo Therapeutics, Inc. | 240.29M | -6.51% | 206,204 | - |
| 255 | JBIO | Jade Biosciences, Inc. | 235.97M | -6.51% | 116,595 | - |
| 256 | TENX | Tenax Therapeutics, Inc. | 234.19M | -3.44% | 6,805 | - |
| 257 | TLSA | Tiziana Life Sciences Ltd | 232.96M | -10.30% | 395,202 | - |
| 258 | OABI | OmniAb, Inc. | 230.68M | -2.59% | 1,941,583 | 23.03M |
| 259 | CDXS | Codexis, Inc. | 230.31M | -2.80% | 552,949 | 49.82M |
| 260 | ALLO | Allogene Therapeutics, Inc. | 229.67M | -0.94% | 8,565,518 | 22.00K |
| 261 | DRUG | Bright Minds Biosciences Inc. | 229.40M | -2.22% | 77,708 | - |
| 262 | DSGN | Design Therapeutics, Inc. | 225.37M | -9.20% | 61,872 | - |
| 263 | FENC | Fennec Pharmaceuticals Inc. | 222.88M | -1.10% | 48,035 | 30.91M |
| 264 | LCTX | Lineage Cell Therapeutics, Inc. | 217.12M | -3.95% | 1,009,035 | 9.56M |
| 265 | CRGX | CARGO Therapeutics, Inc. | 216.67M | 0.45% | 984,964 | - |
| 266 | TVRD | Tvardi Therapeutics, Inc. | 216.30M | -4.23% | 13,987 | - |
| 267 | PRQR | ProQR Therapeutics N.V. | 215.95M | -0.49% | 308,953 | 20.13M |
| 268 | EDIT | Editas Medicine, Inc. | 208.45M | -1.58% | 874,669 | 35.84M |
| 269 | ACIU | AC Immune SA | 205.80M | -3.23% | 135,924 | 36.36M |
| 270 | CLLS | Cellectis S.A. | 204.31M | -1.85% | 81,553 | 63.44M |
| 271 | MDWD | MediWound Ltd. | 203.94M | 2.50% | 47,476 | 19.21M |
| 272 | IPHA | Innate Pharma S.A. | 195.95M | -0.23% | 2,898 | 20.83M |
| 273 | GNFT | Genfit S.A. | 193.32M | -2.23% | 4,081 | 73.19M |
| 274 | EPRX | Eupraxia Pharmaceuticals Inc. | 192.83M | -0.65% | 3,704 | - |
| 275 | TRDA | Entrada Therapeutics, Inc. | 188.08M | -11.09% | 499,459 | 79.48M |
| 276 | CCCC | C4 Therapeutics, Inc. | 183.20M | 31.63% | 9,159,068 | 34.24M |
| 277 | ENGN | enGene Holdings Inc. | 182.45M | -7.99% | 44,229 | - |
| 278 | ENGNW | enGene Holdings Inc. | 182.45M | - | 450 | - |
| 279 | VYGR | Voyager Therapeutics, Inc. | 178.18M | -5.29% | 959,372 | 42.58M |
| 280 | LYEL | Lyell Immunopharma, Inc. | 174.98M | 2.35% | 49,831 | 65.00K |
| 281 | CYBN | Cybin Inc. | 174.82M | 1.74% | 265,922 | - |
| 282 | CTNM | Contineum Therapeutics, Inc. | 174.12M | 6.32% | 208,563 | - |
| 283 | TIL | Instil Bio, Inc. | 170.16M | -1.41% | 131,521 | - |
| 284 | ACRS | Aclaris Therapeutics, Inc. | 170.00M | 1.29% | 612,042 | 16.79M |
| 285 | RAPT | RAPT Therapeutics, Inc. | 169.49M | 2.60% | 29,731 | - |
| 286 | TVGN | Tevogen Bio Holdings Inc. | 168.34M | -8.75% | 1,698,507 | - |
| 287 | CRBU | Caribou Biosciences, Inc. | 168.34M | -3.72% | 1,143,020 | 9.92M |
| 288 | IMA | ImageneBio, Inc. | 168.28M | -4.44% | 10,170 | 4.30M |
| 289 | VTYX | Ventyx Biosciences, Inc. | 167.94M | -6.72% | 686,328 | - |
| 290 | ACTU | Actuate Therapeutics, Inc. | 165.20M | -1.22% | 39,715 | - |
| 291 | MEIP | MEI Pharma, Inc. | 165.07M | 2.41% | 440,296 | - |
| 292 | ELDN | Eledon Pharmaceuticals, Inc. | 164.38M | -20.20% | 3,628,294 | - |
| 293 | PBYI | Puma Biotechnology, Inc. | 163.31M | 1.23% | 504,781 | 238.06M |
| 294 | ASMB | Assembly Biosciences, Inc. | 162.81M | 9.21% | 145,335 | 33.25M |
| 295 | CRDF | Cardiff Oncology, Inc. | 160.33M | -1.23% | 1,745,922 | 545.00K |
| 296 | SLS | SELLAS Life Sciences Group, Inc. | 159.64M | 0.63% | 1,530,953 | - |
| 297 | NVCT | Nuvectis Pharma, Inc. | 157.07M | -4.49% | 267,591 | - |
| 298 | GLSI | Greenwich LifeSciences, Inc. | 156.01M | -3.55% | 81,078 | - |
| 299 | CBIO | Crescent Biopharma, Inc. | 152.82M | - | 101,474 | - |
| 300 | ENTA | Enanta Pharmaceuticals, Inc. | 149.42M | -1.83% | 101,796 | 64.46M |
| 301 | KRRO | Korro Bio, Inc. | 148.93M | 1.02% | 84,732 | 4.82M |
| 302 | MIST | Milestone Pharmaceuticals Inc. | 147.79M | -1.31% | 578,163 | - |
| 303 | THTX | Theratechnologies Inc. | 147.72M | 0.94% | 202,684 | 84.38M |
| 304 | ACOG | Alpha Cognition Inc. | 146.26M | -2.35% | 55,966 | 2.93M |
| 305 | ALEC | Alector, Inc. | 145.99M | 2.10% | 651,832 | 88.34M |
| 306 | ELTX | Elicio Therapeutics, Inc. | 144.96M | -3.20% | 35,383 | - |
| 307 | ADTX | Aditxt, Inc. | 144.76M | 11.93% | 1,059,892 | 55.32K |
| 308 | KYTX | Kyverna Therapeutics, Inc. | 143.05M | -0.60% | 365,697 | - |
| 309 | NKTX | Nkarta, Inc. | 142.62M | -3.83% | 481,761 | - |
| 310 | OBIO | Orchestra BioMed Holdings, Inc. | 140.28M | -1.52% | 429,745 | 2.89M |
| 311 | CGEN | Compugen Ltd. | 134.66M | -1.37% | 331,508 | 22.14M |
| 312 | MCRB | Seres Therapeutics, Inc. | 133.52M | 10.88% | 289,235 | - |
| 313 | ACHV | Achieve Life Sciences, Inc. | 131.17M | - | 925,382 | - |
| 314 | AGEN | Agenus Inc. | 130.50M | - | 626,710 | 99.52M |
| 315 | CABA | Cabaletta Bio, Inc. | 130.42M | - | 1,041,123 | - |
| 316 | BDTX | Black Diamond Therapeutics, Inc. | 129.65M | -15.24% | 1,878,524 | 70.00M |
| 317 | IMRX | Immuneering Corporation | 126.31M | -0.28% | 199,171 | - |
| 318 | FBRX | Forte Biosciences, Inc. | 125.80M | -2.65% | 127,856 | - |
| 319 | LIMN | Liminatus Pharma, Inc. | 125.65M | 2.77% | 128,492 | - |
| 320 | GNLX | Genelux Corporation | 124.67M | -6.96% | 79,143 | 8.00K |
| 321 | IOBT | IO Biotech, Inc. | 124.51M | -3.57% | 364,745 | - |
| 322 | SPRO | Spero Therapeutics, Inc. | 121.33M | -3.98% | 1,003,239 | 44.58M |
| 323 | PLX | Protalix BioTherapeutics, Inc. | 120.21M | 2.03% | 626,245 | 59.76M |
| 324 | TARA | Protara Therapeutics, Inc. | 119.60M | -0.32% | 242,580 | - |
| 325 | OKYO | OKYO Pharma Limited | 118.85M | 2.60% | 59,816 | - |
| 326 | SEER | Seer, Inc. | 118.28M | -2.43% | 180,409 | 16.29M |
| 327 | MOLN | Molecular Partners AG | 116.11M | -0.29% | 1,281 | 2.53M |
| 328 | IKT | Inhibikase Therapeutics, Inc. | 115.23M | -10.40% | 136,153 | 1.00 |
| 329 | CNTB | Connect Biopharma Holdings Limited | 115.01M | -2.82% | 81,185 | 26.03M |
| 330 | SGMO | Sangamo Therapeutics, Inc. | 114.67M | -8.93% | 11,451,112 | 63.76M |
| 331 | CLYM | Climb Bio, Inc. | 113.53M | -4.00% | 272,183 | - |
| 332 | HURA | TuHURA Biosciences, Inc. | 113.11M | -7.25% | 143,653 | - |
| 333 | FATE | Fate Therapeutics, Inc. | 112.35M | -5.76% | 1,444,454 | 13.34M |
| 334 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 110.13M | -1.21% | 88,671 | - |
| 335 | SKYE | Skye Bioscience, Inc. | 109.99M | -8.74% | 443,687 | - |
| 336 | TNYA | Tenaya Therapeutics, Inc. | 107.88M | -1.69% | 1,935,554 | - |
| 337 | SAVA | Cassava Sciences, Inc. | 105.79M | -6.41% | 579,097 | - |
| 338 | ZNTL | Zentalis Pharmaceuticals, Inc. | 104.33M | 5.07% | 1,138,775 | 26.87M |
| 339 | PLRX | Pliant Therapeutics, Inc. | 103.13M | -0.59% | 566,153 | - |
| 340 | ADAG | Adagene Inc. | 102.70M | -8.02% | 110,999 | 103.20K |
| 341 | CHRS | Coherus Oncology, Inc. | 102.47M | -3.47% | 2,050,937 | 272.25M |
| 342 | HLVX | HilleVax, Inc. | 102.19M | 0.49% | 1,379,152 | - |
| 343 | COYA | Coya Therapeutics, Inc. | 102.02M | -4.69% | 26,441 | 3.69M |
| 344 | MGNX | MacroGenics, Inc. | 101.58M | - | 256,381 | 154.05M |
| 345 | VTVT | vTv Therapeutics Inc. | 101.02M | -3.55% | 642 | 17.00K |
| 346 | ATOS | Atossa Therapeutics, Inc. | 99.76M | -1.97% | 708,303 | - |
| 347 | ANEB | Anebulo Pharmaceuticals, Inc. | 98.60M | -11.11% | 217,660 | - |
| 348 | ANIX | Anixa Biosciences, Inc. | 96.96M | -2.90% | 58,025 | - |
| 349 | BMEA | Biomea Fusion, Inc. | 94.75M | 2.52% | 1,379,736 | - |
| 350 | NAUT | Nautilus Biotechnology, Inc. | 94.07M | -5.43% | 170,142 | - |
| 351 | TCRX | TScan Therapeutics, Inc. | 93.37M | -4.62% | 264,023 | 4.42M |
| 352 | ZURA | Zura Bio Limited | 91.57M | -2.63% | 170,875 | - |
| 353 | ONCY | Oncolytics Biotech Inc. | 91.39M | -1.60% | 548,313 | - |
| 354 | NTHI | NeOnc Technologies Holdings, Inc. | 91.33M | -3.03% | 38,277 | 79.99K |
| 355 | AVTX | Avalo Therapeutics, Inc. | 90.41M | 0.48% | 857,068 | 441.00K |
| 356 | IVVD | Invivyd, Inc. | 90.40M | 5.10% | 1,562,179 | 36.69M |
| 357 | QNCX | Quince Therapeutics, Inc. | 89.55M | 0.60% | 274,744 | - |
| 358 | VXRT | Vaxart, Inc. | 89.13M | -2.36% | 393,111 | 47.40M |
| 359 | XBIT | XBiotech Inc. | 89.02M | 0.69% | 50,918 | - |
| 360 | QNTM | Quantum BioPharma Ltd. | 87.85M | -0.50% | 342,836 | - |
| 361 | IMUX | Immunic, Inc. | 86.46M | -7.87% | 1,748,095 | - |
| 362 | ABOS | Acumen Pharmaceuticals, Inc. | 86.01M | 1.43% | 318,620 | - |
| 363 | ARMP | Armata Pharmaceuticals, Inc. | 85.42M | -8.70% | 7,016 | 4.70M |
| 364 | IPA | ImmunoPrecise Antibodies Ltd. | 85.39M | -2.12% | 697,895 | 17.74M |
| 365 | ORMP | Oramed Pharmaceuticals Inc. | 84.96M | -0.24% | 99,883 | 2.00M |
| 366 | EPIX | ESSA Pharma Inc. | 84.24M | 1.60% | 1,026,073 | - |
| 367 | CSBR | Champions Oncology, Inc. | 84.18M | -6.72% | 58,104 | 56.94M |
| 368 | EXOZ | eXoZymes, Inc. | 83.76M | - | 96 | -700.00 |
| 369 | ANRO | Alto Neuroscience, Inc. | 82.84M | -1.29% | 98,708 | - |
| 370 | BYSI | BeyondSpring Inc. | 82.26M | -0.49% | 15,668 | 1.88M |
| 371 | ENTX | Entera Bio Ltd. | 81.81M | -9.09% | 204,176 | 223.00K |
| 372 | VTGN | Vistagen Therapeutics, Inc. | 81.52M | -8.08% | 512,559 | 486.00K |
| 373 | CRVO | CervoMed Inc. | 81.28M | -3.61% | 151,117 | 9.31M |
| 374 | WHWK | Whitehawk Therapeutics, Inc. | 81.03M | -4.44% | 21,874 | 21.60M |
| 375 | VANI | Vivani Medical, Inc. | 80.57M | -2.16% | 133,309 | - |
| 376 | CELU | Celularity Inc. | 80.24M | 0.93% | 54,949 | 54.22M |
| 377 | OTLK | Outlook Therapeutics, Inc. | 78.85M | -2.13% | 818,373 | - |
| 378 | NTRB | Nutriband Inc. | 78.58M | 1.58% | 21,960 | 2.40M |
| 379 | ATHE | Alterity Therapeutics Limited | 77.80M | 3.11% | 17,821 | 2.30M |
| 380 | SRZN | Surrozen, Inc. | 77.32M | -12.84% | 8,409 | 11.64M |
| 381 | IGMS | IGM Biosciences, Inc. | 76.57M | -0.78% | 226,192 | 145.05M |
| 382 | PMVP | PMV Pharmaceuticals, Inc. | 75.33M | -4.61% | 235,973 | - |
| 383 | ATRA | Atara Biotherapeutics, Inc. | 74.48M | -3.78% | 23,414 | 199.73M |
| 384 | INMB | INmune Bio, Inc. | 74.17M | 1.09% | 1,367,486 | 50.00K |
| 385 | CBUS | Cibus, Inc. | 73.90M | -5.45% | 107,118 | 4.75M |
| 386 | INO | Inovio Pharmaceuticals, Inc. | 73.38M | -1.37% | 697,611 | 283.10K |
| 387 | MGX | Metagenomi, Inc. | 71.77M | -8.57% | 644,785 | 45.26M |
| 388 | GNTA | Genenta Science S.p.A. | 68.59M | -1.32% | 886 | - |
| 389 | STRO | Sutro Biopharma, Inc. | 67.57M | -2.16% | 185,157 | 66.43M |
| 390 | MNOV | MediciNova, Inc. | 67.19M | 0.74% | 15,766 | - |
| 391 | IMMX | Immix Biopharma, Inc. | 66.57M | -7.90% | 366,895 | - |
| 392 | PYXS | Pyxis Oncology, Inc. | 66.28M | 1.91% | 142,932 | 16.15M |
| 393 | GUTS | Fractyl Health, Inc. | 66.17M | -3.69% | 1,971,170 | 60.00K |
| 394 | RPTX | Repare Therapeutics Inc. | 65.19M | -0.65% | 103,541 | 1.07M |
| 395 | IRD | Opus Genetics, Inc. | 65.03M | -0.91% | 72,141 | 13.65M |
| 396 | ARTV | Artiva Biotherapeutics, Inc. | 64.32M | -8.01% | 57,001 | 251.00K |
| 397 | CNTX | Context Therapeutics Inc. | 62.70M | - | 83,299 | - |
| 398 | APLT | Applied Therapeutics, Inc. | 61.33M | -2.52% | 581,679 | 265.00K |
| 399 | CUE | Cue Biopharma, Inc. | 61.03M | 3.45% | 70,393 | 7.99M |
| 400 | OSTX | OS Therapies Incorporated | 58.51M | - | 2,902,085 | - |
| 401 | BRNS | Barinthus Biotherapeutics plc | 58.49M | 10.69% | 35,538 | 14.97M |
| 402 | ANL | Adlai Nortye Ltd. | 57.20M | - | 9,648 | 1.94M |
| 403 | ACET | Adicet Bio, Inc. | 56.83M | -1.97% | 92,171 | - |
| 404 | VRCA | Verrica Pharmaceuticals Inc. | 56.51M | -0.08% | 19,053 | 7.18M |
| 405 | CVM | CEL-SCI Corporation | 56.14M | -9.96% | 252,823 | - |
| 406 | ICCC | ImmuCell Corporation | 55.49M | -0.81% | 3,496 | 27.30M |
| 407 | IFRX | InflaRx N.V. | 55.22M | -2.96% | 673,720 | 191.22K |
| 408 | FBIO | Fortress Biotech, Inc. | 54.70M | -1.60% | 84,519 | 57.78M |
| 409 | VERU | Veru Inc. | 54.69M | 2.08% | 1,186,295 | 16.89M |
| 410 | SER | Serina Therapeutics, Inc. | 54.32M | 3.61% | 11,414 | 51.00K |
| 411 | LTRN | Lantern Pharma Inc. | 53.82M | -2.92% | 242,073 | - |
| 412 | HOWL | Werewolf Therapeutics, Inc. | 52.95M | -0.84% | 68,509 | 1.14M |
| 413 | RENB | Renovaro Inc. | 51.96M | -6.37% | 1,058,077 | - |
| 414 | TELO | Telomir Pharmaceuticals, Inc. | 51.54M | -9.24% | 426,786 | - |
| 415 | GANX | Gain Therapeutics, Inc. | 51.51M | -3.56% | 285,468 | - |
| 416 | UNCY | Unicycive Therapeutics, Inc. | 51.32M | -2.17% | 293,042 | - |
| 417 | PDSB | PDS Biotechnology Corporation | 51.20M | 0.90% | 363,182 | - |
| 418 | ADVM | Adverum Biotechnologies, Inc. | 51.18M | -2.78% | 131,242 | 1.00M |
| 419 | KLRS | Kalaris Therapeutics, Inc. | 50.68M | 2.65% | 27,616 | - |
| 420 | DTIL | Precision BioSciences, Inc. | 50.67M | -4.99% | 87,103 | 1.26M |
| 421 | ANVS | Annovis Bio, Inc. | 50.66M | -2.62% | 103,421 | - |
| 422 | INKT | MiNK Therapeutics, Inc. | 50.46M | -3.06% | 124,120 | - |
| 423 | ALGS | Aligos Therapeutics, Inc. | 50.01M | 1.12% | 114,374 | 3.17M |
| 424 | KLTO | Klotho Neurosciences, Inc. | 49.64M | -0.97% | 1,126,125 | - |
| 425 | ATNM | Actinium Pharmaceuticals, Inc. | 48.67M | -2.50% | 65,475 | 81.00K |
| 426 | PRLD | Prelude Therapeutics Incorporated | 48.39M | 0.85% | 161,850 | 7.00M |
| 427 | NRXP | NRx Pharmaceuticals, Inc. | 47.98M | 0.20% | 101,573 | - |
| 428 | XCUR | Exicure, Inc. | 46.50M | -4.29% | 42,295 | 500.00K |
| 429 | KALA | KALA BIO, Inc. | 46.20M | -2.19% | 110,168 | - |
| 430 | PSTV | Plus Therapeutics, Inc. | 45.90M | -0.13% | 9,723,117 | 5.21M |
| 431 | IPSC | Century Therapeutics, Inc. | 45.60M | -2.43% | 419,812 | 114.90M |
| 432 | MAIA | MAIA Biotechnology, Inc. | 44.85M | -2.63% | 142,248 | - |
| 433 | RNXT | RenovoRx, Inc. | 43.89M | - | 40,663 | 240.00K |
| 434 | ABVC | ABVC BioPharma, Inc. | 42.58M | -8.39% | 382,806 | 508.38K |
| 435 | JUNS | Jupiter Neurosciences, Inc. | 42.37M | 4.92% | 82,866 | - |
| 436 | CGTX | Cognition Therapeutics, Inc. | 41.97M | -4.78% | 1,743,030 | - |
| 437 | JSPR | Jasper Therapeutics, Inc. | 41.01M | -5.86% | 380,863 | - |
| 438 | GRCE | Grace Therapeutics, Inc. | 40.79M | -0.67% | 40,186 | - |
| 439 | SLGL | Sol-Gel Technologies Ltd. | 40.70M | 8.71% | 10,960 | 12.10M |
| 440 | CALC | CalciMedica, Inc. | 40.66M | -3.00% | 20,771 | - |
| 441 | LVTX | LAVA Therapeutics N.V. | 40.25M | - | 199,594 | 4.99M |
| 442 | SNTI | Senti Biosciences, Inc. | 40.15M | -8.88% | 162,332 | - |
| 443 | ACRV | Acrivon Therapeutics, Inc. | 39.82M | -1.55% | 160,559 | - |
| 444 | PEPG | PepGen Inc. | 38.94M | -13.14% | 871,857 | - |
| 445 | PLUR | Pluri Inc. | 38.02M | -3.69% | 18,924 | 1.03M |
| 446 | ALXO | ALX Oncology Holdings Inc. | 37.67M | 0.54% | 595,550 | - |
| 447 | STTK | Shattuck Labs, Inc. | 37.41M | -4.63% | 784,716 | 4.61M |
| 448 | COEP | Coeptis Therapeutics Holdings, Inc. | 37.07M | -4.87% | 24,726 | 62.87K |
| 449 | RADX | Radiopharm Theranostics Limited | 36.89M | -3.94% | 14,832 | 204.61K |
| 450 | CLGN | CollPlant Biotechnologies Ltd. | 36.62M | 3.97% | 48,170 | 2.47M |
| 451 | OVID | Ovid Therapeutics Inc. | 36.37M | 0.25% | 431,694 | 548.00K |
| 452 | RANI | Rani Therapeutics Holdings, Inc. | 36.01M | -3.04% | 763,593 | 1.20M |
| 453 | DYAI | Dyadic International, Inc. | 34.37M | -3.58% | 73,954 | 3.55M |
| 454 | KPTI | Karyopharm Therapeutics Inc. | 34.30M | -1.49% | 211,421 | 142.13M |
| 455 | XLO | Xilio Therapeutics, Inc. | 33.94M | -0.73% | 501,505 | 9.27M |
| 456 | MRSN | Mersana Therapeutics, Inc. | 32.95M | -1.34% | 88,673 | 34.01M |
| 457 | AKTX | Akari Therapeutics, Plc | 32.94M | 2.54% | 16,898 | - |
| 458 | PYPD | PolyPid Ltd. | 32.71M | -1.53% | 86,337 | - |
| 459 | ANTX | AN2 Therapeutics, Inc. | 32.59M | 0.47% | 11,680 | - |
| 460 | FGEN | FibroGen, Inc. | 32.09M | 11.75% | 96,571 | 7.00M |
| 461 | ENLV | Enlivex Therapeutics Ltd. | 31.98M | - | 214,109 | - |
| 462 | NRSN | NeuroSense Therapeutics Ltd. | 31.19M | -2.99% | 227,198 | - |
| 463 | HYPD | Hyperion DeFi, Inc. | 30.82M | 0.92% | 449,476 | 67.06K |
| 464 | ESLA | Estrella Immunopharma, Inc. | 30.45M | 0.31% | 31,485 | - |
| 465 | CLSD | Clearside Biomedical, Inc. | 30.07M | -7.08% | 611,050 | 3.76M |
| 466 | ITRM | Iterum Therapeutics plc | 29.26M | -0.79% | 758,369 | - |
| 467 | RVPH | Reviva Pharmaceuticals Holdings, Inc. | 29.15M | -4.73% | 1,715,562 | - |
| 468 | MURA | Mural Oncology plc | 29.10M | -5.62% | 338,822 | - |
| 469 | KZR | Kezar Life Sciences, Inc. | 29.08M | -2.93% | 31,284 | - |
| 470 | CAMP | Camp4 Therapeutics Corporation | 28.82M | -5.92% | 18,785 | 1.51M |
| 471 | TPST | Tempest Therapeutics, Inc. | 28.73M | -0.57% | 61,776 | - |
| 472 | IGC | IGC Pharma, Inc. | 28.44M | -1.65% | 604,756 | 1.27M |
| 473 | LSB | LakeShore Biopharma Co., Ltd | 28.13M | 3.03% | 125,049 | 84.75M |
| 474 | GBIO | Generation Bio Co. | 27.82M | -3.04% | 53,272 | 24.56M |
| 475 | OKUR | OnKure Therapeutics, Inc. | 27.16M | -1.47% | 58,310 | - |
| 476 | LIXT | Lixte Biotechnology Holdings, Inc. | 26.08M | 8.82% | 115,215 | - |
| 477 | RNTX | Rein Therapeutics Inc. | 25.58M | -3.90% | 37,811 | - |
| 478 | BOLD | Boundless Bio, Inc. | 25.52M | -3.39% | 84,081 | - |
| 479 | NNVC | NanoViricides, Inc. | 25.39M | -0.63% | 140,856 | - |
| 480 | LSTA | Lisata Therapeutics, Inc. | 24.07M | -5.41% | 73,531 | 1.00M |
| 481 | NRXS | NeurAxis, Inc. | 23.72M | - | 58,012 | 2.93M |
| 482 | CASI | CASI Pharmaceuticals, Inc. | 22.77M | -12.50% | 301,957 | 31.37M |
| 483 | PRTG | Portage Biotech Inc. | 22.72M | 15.26% | 135,005 | - |
| 484 | FBLG | FibroBiologics, Inc. | 22.38M | -0.41% | 430,135 | - |
| 485 | BCAB | BioAtla, Inc. | 22.19M | 1.41% | 334,145 | 11.00M |
| 486 | CING | Cingulate Inc. | 22.16M | -6.86% | 121,041 | - |
| 487 | ADAP | Adaptimmune Therapeutics plc | 22.00M | 3.36% | 58,741,822 | 179.64M |
| 488 | QTTB | Q32 Bio Inc. | 21.83M | -8.21% | 154,894 | - |
| 489 | ICU | SeaStar Medical Holding Corporation | 21.76M | -1.37% | 765,975 | 428.00K |
| 490 | CVKD | Cadrenal Therapeutics, Inc. | 21.66M | -3.38% | 17,468 | - |
| 491 | GDTC | CytoMed Therapeutics Limited | 21.46M | 1.09% | 326 | 368.84K |
| 492 | RLYB | Rallybio Corporation | 21.26M | -3.16% | 324,118 | 761.00K |
| 493 | CRIS | Curis, Inc. | 20.99M | 2.69% | 56,504 | 11.41M |
| 494 | SABS | SAB Biotherapeutics, Inc. | 20.72M | 1.83% | 153,609 | 114.70K |
| 495 | BTAI | BioXcel Therapeutics, Inc. | 20.65M | 2.71% | 14,771,145 | 1.85M |
| 496 | MBRX | Moleculin Biotech, Inc. | 20.46M | 3.31% | 625,918 | - |
| 497 | RLMD | Relmada Therapeutics, Inc. | 19.98M | 0.48% | 66,356 | - |
| 498 | EQ | Equillium, Inc. | 19.75M | -13.25% | 1,538,137 | 30.41M |
| 499 | LGVN | Longeveron Inc. | 19.06M | -15.05% | 501,710 | 2.23M |
| 500 | PULM | Pulmatrix, Inc. | 18.81M | -3.01% | 10,874 | 369.00K |
| 501 | CMMB | Chemomab Therapeutics Ltd. | 18.59M | -1.02% | 114,883 | - |
| 502 | EVAX | Evaxion A/S | 18.51M | 3.53% | 108,235 | 3.29M |
| 503 | DARE | Daré Bioscience, Inc. | 18.05M | -9.73% | 680,526 | 25.91K |
| 504 | SONN | Sonnet BioTherapeutics Holdings, Inc. | 18.04M | -3.36% | 405,966 | 1.00M |
| 505 | PMN | ProMIS Neurosciences, Inc. | 17.98M | -6.76% | 519,603 | - |
| 506 | IMNN | Imunon, Inc. | 17.52M | -2.71% | 213,187 | - |
| 507 | PASG | Passage Bio, Inc. | 17.51M | -0.80% | 21,405 | - |
| 508 | CLDI | Calidi Biotherapeutics, Inc. | 17.43M | -6.80% | 193,413 | - |
| 509 | PTIX | Protagenic Therapeutics, Inc. | 17.39M | -2.08% | 32,425 | - |
| 510 | GOVX | GeoVax Labs, Inc. | 16.98M | 1.30% | 411,458 | 6.14M |
| 511 | COCP | Cocrystal Pharma, Inc. | 16.79M | -1.20% | 73,845 | - |
| 512 | HOTH | Hoth Therapeutics, Inc. | 16.51M | -5.30% | 181,259 | - |
| 513 | BLRX | BioLineRx Ltd. | 16.41M | -6.17% | 36,150 | 22.34M |
| 514 | ASBP | Aspire Biopharma Holdings, Inc. | 16.30M | 4.09% | 332,951 | - |
| 515 | LEXX | Lexaria Bioscience Corp. | 16.23M | -1.07% | 117,397 | 615.92K |
| 516 | KAPA | Kairos Pharma, Ltd. | 16.18M | -1.32% | 336,724 | - |
| 517 | LPCN | Lipocine Inc. | 16.15M | -1.32% | 16,228 | 4.21M |
| 518 | SYBX | Synlogic, Inc. | 15.92M | -1.38% | 3,220 | 8.00K |
| 519 | PHGE | BiomX Inc. | 15.55M | -8.63% | 11,445,411 | - |
| 520 | ALLR | Allarity Therapeutics, Inc. | 14.87M | -2.34% | 206,328 | - |
| 521 | EDSA | Edesa Biotech, Inc. | 14.69M | -7.11% | 40,245 | - |
| 522 | NEUP | Neuphoria Therapeutics Inc. | 14.57M | -1.15% | 9,841 | 15.66M |
| 523 | ABP | Abpro Holdings, Inc. | 14.56M | -7.31% | 5,042,948 | 183.00K |
| 524 | ATHA | Athira Pharma, Inc. | 14.45M | -2.37% | 42,593 | - |
| 525 | CTXR | Citius Pharmaceuticals, Inc. | 14.42M | 0.78% | 192,139 | - |
| 526 | CYCC | Cyclacel Pharmaceuticals, Inc. | 14.21M | 21.05% | 463,402 | 14.00K |
| 527 | MRKR | Marker Therapeutics, Inc. | 13.92M | 1.65% | 176,946 | 5.70M |
| 528 | NXTC | NextCure, Inc. | 13.63M | -1.26% | 27,161 | - |
| 529 | CLRB | Cellectar Biosciences, Inc. | 13.46M | -1.46% | 65,825 | - |
| 530 | PTHS | Pelthos Therapeutics Inc. | 13.15M | -0.45% | 11,870 | - |
| 531 | PLRZ | Polyrizon Ltd. | 13.10M | 0.87% | 617,069 | - |
| 532 | LPTX | Leap Therapeutics, Inc. | 13.09M | -3.16% | 319,559 | - |
| 533 | XTLB | XTL Biopharmaceuticals Ltd. | 12.85M | 2.16% | 7,404 | 451.00K |
| 534 | CANF | Can-Fite BioPharma Ltd. | 12.75M | 1.40% | 120,545 | 674.00K |
| 535 | NERV | Minerva Neurosciences, Inc. | 12.56M | -0.58% | 2,061 | - |
| 536 | NCNA | NuCana plc | 12.52M | -18.81% | 203,939,619 | - |
| 537 | MTVA | MetaVia Inc. | 12.46M | 3.04% | 92,373 | - |
| 538 | BCTX | BriaCell Therapeutics Corp. | 12.37M | 8.49% | 939,424 | - |
| 539 | ERNA | Ernexa Therapeutics Inc. | 12.13M | -1.94% | 16,755 | 535.00K |
| 540 | OSRH | OSR Holdings, Inc. | 11.93M | -6.35% | 216,730 | -148.95K |
| 541 | MLEC | Moolec Science SA | 11.84M | -1.70% | 8,080 | 7.83M |
| 542 | IMRN | Immuron Limited | 11.51M | -1.22% | 29,974 | 4.05M |
| 543 | CARM | Carisma Therapeutics, Inc. | 11.49M | -9.90% | 657,771 | 19.96M |
| 544 | EVGN | Evogene Ltd. | 11.11M | -1.60% | 16,748 | 6.77M |
| 545 | LYRA | Lyra Therapeutics, Inc. | 11.01M | 1.62% | 26,777 | 1.19M |
| 546 | CSCI | COSCIENS Biopharma Inc. | 10.89M | -6.74% | 2,919 | 9.03M |
| 547 | BOLT | Bolt Biotherapeutics, Inc. | 10.81M | 0.53% | 9,145 | 3.64M |
| 548 | PHIO | Phio Pharmaceuticals Corp. | 10.80M | -3.43% | 161,551 | - |
| 549 | SNGX | Soligenix, Inc. | 10.74M | 2.81% | 2,171,178 | 2.34K |
| 550 | BRTX | BioRestorative Therapies, Inc. | 10.73M | -2.36% | 18,219 | 391.00K |
| 551 | HOOK | HOOKIPA Pharma Inc. | 10.66M | -6.92% | 589,353 | 9.35M |
| 552 | IBIO | iBio, Inc. | 9.64M | -0.10% | 375,201 | 375.00K |
| 553 | CELZ | Creative Medical Technology Holdings, Inc. | 9.63M | 6.27% | 215,479 | 14.00K |
| 554 | DWTX | Dogwood Therapeutics, Inc. | 9.35M | 2.86% | 30,915 | - |
| 555 | PCSA | Processa Pharmaceuticals, Inc. | 9.31M | 1.58% | 38,218,612 | - |
| 556 | APM | Aptorum Group Limited | 9.22M | - | 64,099 | - |
| 557 | KZIA | Kazia Therapeutics Limited | 9.21M | -4.96% | 12,823 | 1.55M |
| 558 | BCDA | BioCardia, Inc. | 9.16M | -1.75% | 87,087 | 3.00K |
| 559 | APRE | Aprea Therapeutics, Inc. | 9.13M | 0.61% | 102,880 | 1.28M |
| 560 | SNSE | Sensei Biotherapeutics, Inc. | 9.09M | -6.97% | 6,526 | - |
| 561 | RNAZ | TransCode Therapeutics, Inc. | 8.88M | -4.14% | 26,276 | - |
| 562 | XFOR | X4 Pharmaceuticals, Inc. | 8.45M | -7.59% | 994,129 | 31.36M |
| 563 | TRAW | Traws Pharma, Inc. | 8.24M | -2.63% | 18,263 | 227.00K |
| 564 | HCWB | HCW Biologics Inc. | 8.18M | -0.22% | 36,739 | 1.45M |
| 565 | TSBX | Turnstone Biologics Corp. | 8.10M | -2.23% | 609,479 | - |
| 566 | AEON | AEON Biopharma, Inc. | 8.06M | 0.31% | 62,781 | - |
| 567 | APVO | Aptevo Therapeutics Inc. | 7.93M | -1.38% | 51,747 | - |
| 568 | CYCN | Cyclerion Therapeutics, Inc. | 7.54M | -1.46% | 24,335 | 2.17M |
| 569 | GLMD | Galmed Pharmaceuticals Ltd. | 7.48M | -5.52% | 131,538 | - |
| 570 | INAB | IN8bio, Inc. | 7.41M | 2.38% | 56,863 | - |
| 571 | GNPX | Genprex, Inc. | 7.34M | 0.64% | 549,208 | - |
| 572 | KPRX | Kiora Pharmaceuticals, Inc. | 7.27M | -1.65% | 27,640 | 20.00K |
| 573 | ACXP | Acurx Pharmaceuticals, Inc. | 7.15M | -7.92% | 51,492 | - |
| 574 | IBO | Impact BioMedical Inc. | 7.11M | -3.94% | 304,100 | - |
| 575 | ALZN | Alzamend Neuro, Inc. | 7.05M | -1.10% | 56,111 | - |
| 576 | WINT | Windtree Therapeutics, Inc. | 6.99M | 4.63% | 1,335,106 | - |
| 577 | ADXN | Addex Therapeutics Ltd | 6.79M | 0.22% | 380 | 278.51K |
| 578 | CDIO | Cardio Diagnostics Holdings, Inc. | 6.73M | -1.78% | 27,559 | 19.90K |
| 579 | MBIO | Mustang Bio, Inc. | 6.65M | 3.40% | 74,946 | - |
| 580 | PPBT | Purple Biotech Ltd | 6.54M | - | 10,357 | - |
| 581 | NLSP | NLS Pharmaceutics AG | 6.38M | 6.88% | 115,790 | - |
| 582 | INTS | Intensity Therapeutics, Inc. | 6.32M | -7.59% | 2,962,916 | - |
| 583 | VYNE | VYNE Therapeutics Inc. | 6.28M | 3.32% | 4,672,625 | 605.00K |
| 584 | APLM | Apollomics, Inc. | 6.27M | 1.97% | 1,809 | 198.00K |
| 585 | ARTL | Artelo Biosciences, Inc. | 6.17M | 0.33% | 14,196 | - |
| 586 | ADIL | Adial Pharmaceuticals, Inc. | 6.11M | -6.25% | 1,218,811 | - |
| 587 | PMCB | PharmaCyte Biotech, Inc. | 5.84M | 0.68% | 41,939 | - |
| 588 | GTBP | GT Biopharma, Inc. | 5.76M | 5.17% | 33,318 | - |
| 589 | CDT | Conduit Pharmaceuticals Inc. | 5.47M | 0.54% | 31,424 | - |
| 590 | BIVI | BioVie Inc. | 5.40M | -25.58% | 421,815 | - |
| 591 | THAR | Tharimmune, Inc. | 5.32M | 4.13% | 18,033 | - |
| 592 | CMND | Clearmind Medicine Inc. | 5.24M | 6.23% | 66,763 | - |
| 593 | KTTA | Pasithea Therapeutics Corp. | 5.21M | 2.19% | 45,204 | - |
| 594 | TCRT | Alaunos Therapeutics, Inc. | 5.14M | -6.69% | 24,285 | 11.00K |
| 595 | ENSC | Ensysce Biosciences, Inc. | 4.93M | -1.89% | 126,990 | 6.22M |
| 596 | SLXN | Silexion Therapeutics Corp | 4.81M | 3.25% | 29,681 | - |
| 597 | TTNP | Titan Pharmaceuticals, Inc. | 4.66M | 0.51% | 1,434 | - |
| 598 | XBIO | Xenetic Biosciences, Inc. | 4.58M | 2.06% | 6,394 | 2.58M |
| 599 | SILO | Silo Pharma, Inc. | 4.54M | 5.18% | 161,409 | 72.10K |
| 600 | VIVS | VivoSim Labs, Inc. | 4.52M | -2.79% | 42,033 | 144.00K |
| 601 | MTNB | Matinas BioPharma Holdings, Inc. | 4.51M | -1.56% | 40,012 | - |
| 602 | GLTO | Galecto, Inc. | 4.31M | -2.50% | 1,212 | - |
| 603 | SXTP | 60 Degrees Pharmaceuticals, Inc. | 4.26M | -1.86% | 173,720 | 802.32K |
| 604 | BDRX | Biodexa Pharmaceuticals Plc | 4.21M | 0.59% | 29,273 | 104.90K |
| 605 | PALI | Palisade Bio, Inc. | 4.21M | -12.16% | 94,980,621 | - |
| 606 | QNRX | Quoin Pharmaceuticals, Ltd. | 4.06M | -6.24% | 6,509 | - |
| 607 | DRMA | Dermata Therapeutics, Inc. | 4.06M | -2.30% | 36,852 | - |
| 608 | JAGX | Jaguar Health, Inc. | 4.02M | -5.62% | 39,859 | 11.55M |
| 609 | REVB | Revelation Biosciences, Inc. | 3.91M | 2.00% | 55,695 | - |
| 610 | INDP | Indaptus Therapeutics, Inc. | 3.86M | -6.65% | 11,888 | - |
| 611 | XRTX | XORTX Therapeutics Inc. | 3.82M | 5.41% | 166,060 | - |
| 612 | CNSP | CNS Pharmaceuticals, Inc. | 3.70M | -6.17% | 27,838 | - |
| 613 | TOVX | Theriva Biologics, Inc. | 3.53M | -0.08% | 128,983 | - |
| 614 | VRAX | Virax Biolabs Group Limited | 3.43M | 0.62% | 12,795 | 6.33K |
| 615 | NBY | NovaBay Pharmaceuticals, Inc. | 3.38M | -1.53% | 10,954 | 9.78M |
| 616 | CERO | CERo Therapeutics Holdings, Inc. | 3.13M | 1.25% | 30,250 | - |
| 617 | GRI | GRI Bio, Inc. | 3.12M | - | 68,655 | - |
| 618 | QLGN | Qualigen Therapeutics, Inc. | 3.03M | 5.11% | 39,366 | - |
| 619 | AZTR | Azitra, Inc. | 2.89M | -6.67% | 1,102,952 | 7.50K |
| 620 | SPRC | SciSparc Ltd. | 2.83M | -4.68% | 28,495 | 1.31M |
| 621 | ENVB | Enveric Biosciences, Inc. | 2.74M | -3.48% | 124,822 | - |
| 622 | ELAB | PMGC Holdings Inc. | 2.59M | -1.31% | 11,606 | 2.45M |
| 623 | PBM | Psyence Biomedical Ltd. | 2.44M | 2.20% | 207,635 | - |
| 624 | ENTO | Entero Therapeutics, Inc. | 1.85M | -11.59% | 169,896 | - |
| 625 | SCNI | Scinai Immunotherapeutics Ltd. | 1.44M | -3.75% | 132,629 | 658.00K |
| 626 | TNFA | TNF Pharmaceuticals, Inc. | 1.40M | -5.84% | 19,527,357 | - |
| 627 | ONCO | Onconetix, Inc. | 1.39M | -9.18% | 146,512 | 1.93M |
| 628 | SLRX | Salarius Pharmaceuticals, Inc. | 1.18M | 5.50% | 411,932 | - |
| 629 | OGEN | Oragenics, Inc. | 1.07M | -0.76% | 79,104 | - |